tradingkey.logo
搜索

碧迪医疗

BDX
添加自选
143.940USD
+3.230+2.30%
收盘 06/23, 16:00美东报价延迟15分钟
39.66B总市值
36.26市盈率 TTM

碧迪医疗

143.940
+3.230+2.30%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+2.30%

5天

-1.09%

1月

-2.50%

6月

-6.90%

今年开始到现在

-5.62%

1年

+8.75%

关键数据
142.560今开
145.591最高
2.91M成交量
36.26市盈率 TTM
10.70市盈率动
4.180股息TTM
1.06%换手率
140.710昨收
141.250最低
230.78M成交额
23.64市盈率静
1.64市净率
2.90%股息率 TTM
3.13%ROA
187.35052周最高
0.91量比
1.68B净利润
275.54M总股本
3.9693每股收益TTM
0.23Beta
6.67%ROE
127.53652周最低
3.09%振幅
46.58%毛利率
39.66B总市值
-3.22回报/风险
1.45%风险率

TradingKey 碧迪医疗股票评分

单位: USD 更新时间: 2026-06-22

操作建议

碧迪医疗当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名63/203位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价183.44。中期看,股价处于下降通道。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

碧迪医疗评分

相关信息

行业排名
63 / 203
全市场排名
177 / 4577
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
极度看空

碧迪医疗亮点

亮点风险
Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
利润高增长
公司净利润处于行业前列,最新年度总收入21.84B美元
高分红
公司属于高分红公司,最新股息支付率71.28%
稳定分红
公司5年内连续分红,最新股息支付率71.28%
估值合理
公司最新PE估值35.45,处于3年历史合理位
机构减仓
最新机构持股241.06M股,环比减少16.25%
First Pacific Advisors持仓
明星投资者First Pacific Advisors持仓,最新持仓市值2.11M

分析师目标

根据 17 位分析师
买入
评级
183.436
目标均价
+30.36%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

碧迪医疗新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

碧迪医疗简介

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
公司代码BDX
公司碧迪医疗
CEOPolen (Thomas E)
网址https://www.bd.com/

常见问题

碧迪医疗(BDX)的当前股价是多少?

碧迪医疗(BDX)的当前股价是 140.71。

碧迪医疗的股票代码是什么?

碧迪医疗的股票代码是BDX。

碧迪医疗股票的52周最高点是多少?

碧迪医疗股票的52周最高点是187.35。

碧迪医疗股票的52周最低点是多少?

碧迪医疗股票的52周最低点是127.54。

碧迪医疗的市值是多少?

碧迪医疗的市值是38.77B。

现在碧迪医疗(BDX)的股票是买入、持有还是卖出?

根据分析师评级,碧迪医疗(BDX)的总体评级为买入,目标价格为183.44。

碧迪医疗(BDX)股票的每股收益(EPS TTM)是多少

碧迪医疗(BDX)股票的每股收益(EPS TTM)是5.83。
KeyAI